See also this year's filing and all EDGAR filings for this company.
PDF Report 0001035422_2015_CTT_Pharmaceutical_Holdings_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001035422, CTT Pharmaceutical Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | PropertyPlantAndEquipment | 0 |
| 1 | AssetsCurrent | 1,049,734 |
| 2 | AssetsNonCurrent | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | remainder_Assets | 612,636 |
| 5 | LiabilitiesCurrent | 0 |
| 6 | LiabilitiesNonCurrent | 0 |
| 7 | remainder_Liabilities | 1,075,740 |
| 8 | GeneralAndAdministrativeExpense | 17,641 |
| 9 | CostOfRevenue | 0 |
| 10 | DepreciationDepletionAndAmortization | 0 |
| 11 | remainder_Expenses | 654,521 |
| 12 | remainder_Revenues | 0 |
| 13 | remainder_NetIncome | 900,000 |
| 14 | remainder_ComprehensiveNetIncome | 3,098 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,662,370 |
| 1 | Liabilities | 1,075,740 |
| 2 | Expenses | 672,162 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 586,630 |
| 5 | NetIncome | 227,838 |
| 6 | ComprehensiveNetIncome | 230,936 |
| 7 | BaseVar | 2,156,685 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.811 |
| 9 | EconomicCapitalRatio | 1.69 |
Edgar->Model Mapping
Feature Distribution
Change over Time
